Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.
Biol Reprod. 2011 May;84(5):1063-71. doi: 10.1095/biolreprod.110.085928. Epub 2011 Jan 19.
Though the decidua serves a critical function in implantation, the hormonal regulated pathway in decidualization is still elusive. Here we describe in detail the regional distribution and the effects of progesterone receptors (PGR), estrogen receptors (ESR), and MAPK activation on decidualization. We showed an increase in PGR A, PGR B, ESR1, and phosphorylated MAPK3-1 proteins (p-MAPK3-1), but not in ESR2, in the decidual tissue up to Day 8 of pregnancy. PGR was predominantly found in the nuclei of mesometrial decidual cells and of undifferentiated stromal cells where it colocalizes with ESR2 and ESR1. In the antimesometrial decidua, all the receptors showed cytoplasmic localization. MAPK was activated exclusively in undifferentiated stromal cells of the junctional zone between the antimesometrial and mesometrial decidua and at the border of the antimesometrial decidua. Treatment with the progesterone antagonist onapristone and/or the estrogen antagonist faslodex reduced the extent of decidual tissue and downregulated the levels of PGR and ESR1. The expression level of ESR2 was affected only by the progesterone receptor antagonist, while neither the antiprogestin nor the antiestrogen significantly modified the p-MAPK3-1 level. The inhibition of MAPK3-1 phosphorylation by PD98059 impaired the extent of decidualization and the closure reaction of the implantation chamber, and significantly downregulated ESR1. These results confirm a role of both steroid receptors in the growth and differentiation of the different decidual regions and suggest a new function for p-MAPK3-1 in regulating expression levels of ESR1, thereby maintaining the proliferation capacity of stromal cells and limiting the differentiation process in specified regions of decidual tissues.
虽然蜕膜在着床中起着至关重要的作用,但蜕膜化的激素调节途径仍不明确。在这里,我们详细描述了孕激素受体(PGR)、雌激素受体(ESR)和 MAPK 激活对蜕膜化的区域分布和影响。我们发现,妊娠第 8 天之前,蜕膜组织中 PGR A、PGR B、ESR1 和磷酸化 MAPK3-1 蛋白(p-MAPK3-1)增加,但 ESR2 没有增加。PGR 主要存在于中隔蜕膜细胞的核中和未分化的基质细胞中,与 ESR2 和 ESR1 共定位。在反中隔蜕膜中,所有受体均显示细胞质定位。MAPK 仅在反中隔和中隔蜕膜交界处的未分化基质细胞以及反中隔蜕膜的边界处被激活。用孕激素拮抗剂 onapristone 和/或雌激素拮抗剂 faslodex 处理可减少蜕膜组织的程度,并下调 PGR 和 ESR1 的水平。ESR2 的表达水平仅受孕激素受体拮抗剂的影响,而孕激素拮抗剂和雌激素拮抗剂均未显著改变 p-MAPK3-1 水平。PD98059 抑制 MAPK3-1 磷酸化可损害蜕膜化的程度和植入腔的闭合反应,并显著下调 ESR1。这些结果证实了甾体受体在不同蜕膜区域的生长和分化中的作用,并表明 p-MAPK3-1 在调节 ESR1 表达水平方面具有新的功能,从而维持基质细胞的增殖能力并限制蜕膜组织特定区域的分化过程。